Kidney Damage Doesn’t Rule Out Transplants for Myeloma Patients, Brazilian Study Shows
A Brazilian study of 53 myeloma patients with renal impairment shows autologous stem cell transplantation carries high toxicity and intensive ...
A Brazilian study of 53 myeloma patients with renal impairment shows autologous stem cell transplantation carries high toxicity and intensive ...
A Mendelian randomization study finds that inherited differences in cerebral cortical structure are causally linked to blood cancer risk and ...
A 25-year national analysis finds multiple myeloma deaths in the United States fell sharply after 2012 with novel therapies, yet ...
A German case report describes rapid deep response to ciltacabtagene autoleucel as a second BCMA-directed CAR T-cell therapy after mezigdomide-based ...
A single-cell atlas of 341 multiple myeloma patients identifies five malignant transcriptional archetypes and an orthogonal proliferative program, enabling improved ...
A new commentary argues that exceptional long-term responses to melflufen-dexamethasone in myeloma case reports should not override subgroup trial evidence ...
A combined blood-based inflammation and nutrition score strongly predicted survival outcomes in newly diagnosed multiple myeloma patients, improving risk stratification ...
A new study maps distinct inflammatory cytokine and PACAP-38 signatures in multiple myeloma, linking elevated IL-10 and other markers to ...
Multiple myeloma has long challenged researchers because the disease is not driven only by uncontrolled growth. Its malignant plasma cells ...
Multiple myeloma is entering an era of unprecedented therapeutic choice—and equally unprecedented uncertainty. A new clinical perspective by C.R. Tan ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine